Summary Biovica International AB (Biovica) is a biotech company that focuses on the development and commercialization of blood-based biomarker assays. The company’s DiviTum is a biomarker test that has been developed to monitor and predict treatment effectiveness in the treatment of solid tumours. DiviTum assay is used for measuring activity of thymidine kinase-1, an enzyme associated with cell proliferation, in blood serum or cell cultures. It works in collaboration with Karolinska Institute...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.